Dhodapkar M - Search Results

1

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).

Khan R, Dhodapkar M, Rosenthal A, Heuck C, Papanikolaou X, Qu P, van Rhee F, Zangari M, Jethava Y, Epstein J, Yaccoby S, Hoering A, Crowley J, Petty N, Bailey C, Morgan G, Barlogie B. Khan R, et al. Among authors: dhodapkar m. Haematologica. 2015 Sep;100(9):1214-21. doi: 10.3324/haematol.2015.124651. Epub 2015 May 28. Haematologica. 2015. PMID: 26022710 Free PMC article. Clinical Trial.

2

Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.

Dhodapkar MV, Kelly T, Theus A, Athota AB, Barlogie B, Sanderson RD. Dhodapkar MV, et al. Br J Haematol. 1997 Nov;99(2):368-71. doi: 10.1046/j.1365-2141.1997.3893203.x. Br J Haematol. 1997. PMID: 9375756 Free article.

3

Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation.

Desikan KR, Dhodapkar MV, Hough A, Waldron T, Jagannath S, Siegel D, Barlogie B, Tricot G. Desikan KR, et al. Among authors: dhodapkar mv. Leuk Lymphoma. 1997 Oct;27(3-4):315-9. doi: 10.3109/10428199709059685. Leuk Lymphoma. 1997. PMID: 9402328 Clinical Trial.

4

Treatment of AL-amyloidosis with dexamethasone plus alpha interferon.

Dhodapkar MV, Jagannath S, Vesole D, Munshi N, Naucke S, Tricot G, Barlogie B. Dhodapkar MV, et al. Leuk Lymphoma. 1997 Oct;27(3-4):351-6. doi: 10.3109/10428199709059690. Leuk Lymphoma. 1997. PMID: 9402333 Clinical Trial.

5

Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation.

Dhodapkar MV, Abe E, Theus A, Lacy M, Langford JK, Barlogie B, Sanderson RD. Dhodapkar MV, et al. Blood. 1998 Apr 15;91(8):2679-88. Blood. 1998. PMID: 9531576 Free article.

6

Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.

Rudnicki SA, Harik SI, Dhodapkar M, Barlogie B, Eidelberg D. Rudnicki SA, et al. Among authors: dhodapkar m. Neurology. 1998 Oct;51(4):1210-3. doi: 10.1212/wnl.51.4.1210. Neurology. 1998. PMID: 9781565

7

Anti-myeloma activity of pamidronate in vivo.

Dhodapkar MV, Singh J, Mehta J, Fassas A, Desikan KR, Perlman M, Munshi NC, Barlogie B. Dhodapkar MV, et al. Br J Haematol. 1998 Nov;103(2):530-2. doi: 10.1046/j.1365-2141.1998.00976.x. Br J Haematol. 1998. PMID: 9827929 Free article.

8

Biologic and therapeutic determinants of bone mineral density in multiple myeloma.

Dhodapkar MV, Weinstein R, Tricot G, Jagannath S, Parfitt AM, Manolagas SC, Barlogie B. Dhodapkar MV, et al. Leuk Lymphoma. 1998 Dec;32(1-2):121-7. doi: 10.3109/10428199809059252. Leuk Lymphoma. 1998. PMID: 10037007

9

Recent advances in the treatment of multiple myeloma.

Desikan KR, Dhodapkar MV, Munshi NC, Barlogie B. Desikan KR, et al. Among authors: dhodapkar mv. Curr Opin Hematol. 1999 Jul;6(4):216-21. doi: 10.1097/00062752-199907000-00004. Curr Opin Hematol. 1999. PMID: 10400369 Review.

10

Antitumor activity of thalidomide in refractory multiple myeloma.

Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B. Singhal S, et al. Among authors: dhodapkar m. N Engl J Med. 1999 Nov 18;341(21):1565-71. doi: 10.1056/NEJM199911183412102. N Engl J Med. 1999. PMID: 10564685 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters